LinkedIn
ALOOSTA
Contact
The duration for the active substances is usually extended by one year if the review of the authorisation takes longer than originally planned. The list is limited to the organochemical agents.
The approval for the following chemical agents was extended:
|
Active Ingredients |
Limited until |
Reference |
|
Beflubutamid |
07/31/2022 |
|
|
Benthiavalicarb |
07/31/2022 |
|
|
Bifenazate |
07/31/2022 |
|
|
Boscalid |
07/31/2022 |
|
|
Bromoxynil |
No entry |
|
|
Captan |
07/31/2022 |
|
|
Cymoxanil |
08/31/2022 |
|
|
Dimethomorph |
07/31/2022 |
|
|
Ethephon |
07/31/2022 |
|
|
Famoxadone |
30.06.2022 |
|
|
Flumioxazine |
05/31/2022 or |
|
|
Fluoxastrobin |
07/31/2022 |
|
|
Flurochloridone |
No entry |
|
|
Folpet |
07/31/2022 |
|
|
Formetanate |
07/31/2022 |
|
|
Gibberellins |
08/31/2022 |
|
|
Gibberellic acid |
08/31/2022 |
|
|
Heptamaloxyloglucan |
05/31/2022 |
|
|
Metazachlor |
07/31/2022 |
|
|
Metribuzin |
07/31/2022 |
|
|
Milbemectin |
07/31/2022 |
|
|
Phenmedipham |
07/31/2022 |
|
|
Phosmet |
07/31/2022 |
|
|
Pirimiphos-methyl |
07/31/2022 |
|
|
Propamocarb |
07/31/2022 |
|
|
Prothioconazole |
07/31/2022 |
|
|
S-Metolachlor |
07/31/2022 |
|
|
Tebuconazole |
08/31/2022 |
|
|
Cyazofamid |
07/31/2036 |
The extended periods of validity have no influence on the current MRLs and can be withdrawn at any time if an active substance is refused re-approval as part of the approval process.
Author: Dr. Frank Mörsberger
Contact
Career